Skip to content
Screener

Abbott ABT Medical Devices — Net Sales

Other segment segments

Diagnostic Products
$3.09B+42.3%
Nutritional Products
$2.14B-3.1%
Established Pharmaceuticals
$1.5B+8.4%

Similar metrics at other companies

Kimball Electronics logo
KEMedical — Net Sales
$106.1M-7.9%
Medtronic logo
MDTMedical Surgical — Net Sales
$2.39B+8.0%
Baxter International logo
BAXMedical Products & Therapies — Net Sales
$1.29B+1.8%
Axon Enterprise, Inc. logo
AXONConnected Devices — Net Sales
$452.82M+32.8%
Stryker logo
SYKMedical — Net Sales
$902M-4.6%
Logitech International logo
LOGIPointing Devices — Net Sales
$227.31M+16.1%

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$5.1B-26.6%
Total debt$32.6B+143%
Total equity$51.1B+1.1%
Total assets$109.22B+30.0%

Cash flow

See full
Operating cash flow$2.5B+21.5%
CapEx$497.0M-1.0%
Free cash flow$2.0B+28.9%

Valuation

See full
Market cap$182.9B-19.1%
Enterprise value$210.41B-9.6%
P/E33.7×+17.5×
P/S3.9×-1.3×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.8%+1.1pp

Returns & leverage

See full
Return on equity10.7%-20.4pp
Debt / equity0.6×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Abbott’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050134
(in millions)Three Months Ended June 30, 2026 / U.S.Three Months Ended June 30, 2026 / Int’lThree Months Ended June 30, 2026 / TotalThree Months Ended June 30, 2025 / U.S.Three Months Ended June 30, 2025 / Int’lThree Months Ended June 30, 2025 / Total
Heart Failure3138840128286368
Vascular294509803283474757
Structural Heart225372597249332581
Neuromodulation1897126019361254
Diabetes Care8621,3262,1887941,1871,981
Total2,6803,1735,8532,5032,8665,369
Other5555
Total$5,216$7,377$12,593$4,276$6,866$11,142

Item 1. Financial Statements and Supplementary Data

FAQ

What is Abbott's medical devices — net sales?
Abbott (ABT) reported medical devices — net sales of $5.85B in Q2 2026.
How has Abbott's medical devices — net sales changed year-over-year?
Abbott's medical devices — net sales increased by 9.0% year-over-year, from $5.37B to $5.85B.
What is the long-term trend for Abbott's medical devices — net sales?
Over 4 years (2021 to 2025), Abbott's medical devices — net sales has grown at a 10.5% compound annual growth rate (CAGR), from $14.37B to $21.39B.
What does medical devices — net sales mean?
Represents the total revenue generated from the sale of medical devices, including cardiovascular, diabetes, and neuromodulation products. This metric reflects the market demand and commercial success of the segment's product portfolio. It is a primary indicator of the segment's top-line growth and market penetration.

Ask your AI about Abbott's medical devices — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude